Log in
Enquire now
‌

US Patent 11001610 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

Patent 11001610 was granted and assigned to Apellis Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Apellis Pharmaceuticals
Apellis Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110016100
Patent Inventor Names
Pascal Deschatelets0
Cedric Francois0
Date of Patent
May 11, 2021
0
Patent Application Number
161570520
Date Filed
October 10, 2018
0
Patent Citations
‌
US Patent 10125171 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
‌
US Patent 10407466 Methods of selecting compstatin mimetics
‌
US Patent 10308687 Cell-penetrating compstatin analogs and uses thereof
Patent Citations Received
‌
US Patent 11407789 Cell-penetrating compstatin analogs and uses thereof
‌
US Patent 11292815 Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
0
‌
US Patent 11661441 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
0
Patent Primary Examiner
‌
Jeanette M Lieb
0
Patent abstract

In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11001610 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us